A modelling-experimental approach reveals insulin receptor substrate (IRS)-dependent regulation of adenosine monosphosphate-dependent kinase (AMPK) by insulin

FEBS Journal

Volumn 279, Issue 18, 2012, Pages 3314-3328

  Sonntag, Annika G ^a   Dalle Pezze, Piero ^b   Shanley, Daryl P ^b   Thedieck, Kathrin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

adenosine monophosphate dependent kinase; Akt; dynamic network model; insulin; insulin receptor substrate; mammalian target of rapamycin

Indexed keywords

ADENOSINE MONOPHOSPHATE DEPENDENT KINASE; INSULIN; INSULIN RECEPTOR SUBSTRATE; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; EXPERIMENTAL MODEL; INTERMETHOD COMPARISON; MOLECULAR DYNAMICS; MOLECULAR MODEL; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; WILD TYPE;

MAMMALIA;

EID: 85027920901     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2012.08582.x     Document Type: Conference Paper

References (54)

1. Zoncu R, Efeyan A, &, Sabatini DM, (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12, 21-35.
2. Polak P, &, Hall MN, (2009) mTOR and the control of whole body metabolism. Curr Opin Cell Biol 21, 209-218.
3. Sengupta S, Peterson TR, &, Sabatini DM, (2010) Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 40, 310-322.
4. Howell JJ, &, Manning BD, (2011) mTOR couples cellular nutrient sensing to organismal metabolic homeostasis. Trends Endocrinol Metab 22, 94-102.
5. Thedieck K, &, Hall MN, (2009) Translational control by amino acids and energy. In The Handbook of Cell Signaling (, Bradshaw R, &, Dennis E, eds), pp. 2285-2293. Elsevier, Academic Press, Amsterdam.
6. Thedieck K, Polak P, Kim ML, Molle KD, Cohen A, Jeno P, Arrieumerlou C, &, Hall MN, (2007) PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis. PLoS One 2, e1217.
7. Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, &, Kim DH, (2007) Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 9, 316-323. (Pubitemid 46344611)
8. Sancak Y, Thoreen CC, Peterson TR, Lindquist RA, Kang SA, Spooner E, Carr SA, &, Sabatini DM, (2007) PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 25, 903-915. (Pubitemid 46436534)
9. Wang L, Harris TE, Roth RA, &, Lawrence JC Jr, (2007) PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. J Biol Chem 282, 20036-20044. (Pubitemid 47100127)
10. Fonseca BD, Smith EM, Lee VH, MacKintosh C, &, Proud CG, (2007) PRAS40 is a target for mammalian target of rapamycin complex 1 and is required for signaling downstream of this complex. J Biol Chem 282, 24514-24524. (Pubitemid 47347551)
11. Oshiro N, Takahashi R, Yoshino K, Tanimura K, Nakashima A, Eguchi S, Miyamoto T, Hara K, Takehana K, Avruch J, et al. (2007) The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1. J Biol Chem 282, 20329-20339. (Pubitemid 47100038)
12. Wang L, Harris TE, &, Lawrence JC Jr, (2008) Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation. J Biol Chem 283, 15619-15627.
13. Dalle Pezze P, Sonntag AG, Thien A, Prentzell MT, Gödel M, Fischer S, Neumann-Haefelin E, Huber TB, Baumeister R, Shanley DP, et al. (2012) A dynamic network model of mTOR signalling reveals TSC-independent mTORC2 regulation. Sci Signal 5, ra25. doi:10.1126/scisignal.2002469.
14. Mihaylova MM, &, Shaw RJ, (2011) The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 13, 1016-1023.
15. Lizcano JM, Goransson O, Toth R, Deak M, Morrice NA, Boudeau J, Hawley SA, Udd L, Makela TP, Hardie DG, et al. (2004) LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J 23, 833-843. (Pubitemid 38418750)
16. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG, &, Hardie DG, (2005) Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2, 9-19. (Pubitemid 43239821)
17. Fogarty S, Hawley SA, Green KA, Saner N, Mustard KJ, &, Hardie DG, (2010) Calmodulin-dependent protein kinase kinase-beta activates AMPK without forming a stable complex: synergistic effects of Ca2+ and AMP. Biochem J 426, 109-118.
18. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, &, Witters LA, (2005) The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 280, 29060-29066. (Pubitemid 41161355)
19. Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, Carlson M, &, Carling D, (2005) Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2, 21-33. (Pubitemid 43239822)
20. Xie M, Zhang D, Dyck JR, Li Y, Zhang H, Morishima M, Mann DL, Taffet GE, Baldini A, Khoury DS, et al. (2006) A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc Natl Acad Sci USA 103, 17378-17383. (Pubitemid 44788977)
21. Herrero-Martin G, Hoyer-Hansen M, Garcia-Garcia C, Fumarola C, Farkas T, Lopez-Rivas A, &, Jaattela M, (2009) TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells. EMBO J 28, 677-685.
22. Momcilovic M, Hong SP, &, Carlson M, (2006) Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J Biol Chem 281, 25336-25343. (Pubitemid 44401921)
23. Suzuki A, Kusakai G, Kishimoto A, Shimojo Y, Ogura T, Lavin MF, &, Esumi H, (2004) IGF-1 phosphorylates AMPK-alpha subunit in ATM-dependent and LKB1-independent manner. Biochem Biophys Res Commun 324, 986-992. (Pubitemid 39361605)
24. Sun Y, Connors KE, &, Yang DQ, (2007) AICAR induces phosphorylation of AMPK in an ATM-dependent, LKB1-independent manner. Mol Cell Biochem 306, 239-245. (Pubitemid 350001836)
25. Meares GP, Hughes KJ, Naatz A, Papa FR, Urano F, Hansen PA, Benveniste EN, &, Corbett JA, (2011) IRE1-dependent activation of AMPK in response to nitric oxide. Mol Cell Biol 31, 4286-4297.
26. Inoki K, Zhu T, &, Guan KL, (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-590. (Pubitemid 37506046)
27. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, Turk BE, &, Shaw RJ, (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30, 214-226. (Pubitemid 351626684)
28. Polak P, Cybulski N, Feige JN, Auwerx J, Ruegg MA, &, Hall MN, (2008) Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab 8, 399-410.
29. Aguilar V, Alliouachene S, Sotiropoulos A, Sobering A, Athea Y, Djouadi F, Miraux S, Thiaudiere E, Foretz M, Viollet B, et al. (2007) S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase. Cell Metab 5, 476-487. (Pubitemid 46825498)
30. Inoki K, Ouyang H, Li Y, &, Guan KL, (2005) Signaling by target of rapamycin proteins in cell growth control. Microbiol Mol Biol Rev 69, 79-100. (Pubitemid 40358068)
31. Maiwald T, &, Timmer J, (2008) Dynamical modeling and multi-experiment fitting with PottersWheel. Bioinformatics 24, 2037-2043.
32. Chis O, Banga JR, &, Balsa-Canto E, (2011) GenSSI: a software toolbox for structural identifiability analysis of biological models. Bioinformatics 27, 2610-2611.
33. Hengl S, Kreutz C, Timmer J, &, Maiwald T, (2007) Data-based identifiability analysis of non-linear dynamical models. Bioinformatics 23, 2612-2618. (Pubitemid 350048365)
34. Akaike H, (1974) A new look at the statistical model identification. IEEE Trans Automat Contr 19, 716-723.
35. Schwarz G, (1978) Estimating the dimension of a model. Ann Stat 6, 461-464.
36. Tzatsos A, &, Kandror KV, (2006) Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation. Mol Cell Biol 26, 63-76.
37. Kohn AD, Takeuchi F, &, Roth RA, (1996) Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J Biol Chem 271, 21920-21926. (Pubitemid 26303815)
38. Caron E, Ghosh S, Matsuoka Y, Ashton-Beaucage D, Therrien M, Lemieux S, Perreault C, Roux PP, &, Kitano H, (2010) A comprehensive map of the mTOR signaling network. Mol Syst Biol 6, 453.
39. Sedaghat AR, Sherman A, &, Quon MJ, (2002) A mathematical model of metabolic insulin signaling pathways. Am J Physiol Endocrinol Metab 283, E1084-E1101. (Pubitemid 35216969)
40. Jain P, &, Bhalla US, (2009) Signaling logic of activity-triggered dendritic protein synthesis: an mTOR gate but not a feedback switch. PLoS Comput Biol 5, e1000287.
41. Faratian D, Goltsov A, Lebedeva G, Sorokin A, Moodie S, Mullen P, Kay C, Um IH, Langdon S, Goryanin I, et al. (2009) Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab. Cancer Res 69, 6713-6720.
42. Vinod PK, &, Venkatesh KV, (2009) Quantification of the effect of amino acids on an integrated mTOR and insulin signaling pathway. Mol BioSyst 5, 1163-1173.
43. Borisov N, Aksamitiene E, Kiyatkin A, Legewie S, Berkhout J, Maiwald T, Kaimachnikov NP, Timmer J, Hoek JB, &, Kholodenko BN, (2009) Systems-level interactions between insulin-EGF networks amplify mitogenic signaling. Mol Syst Biol 5, 256.
44. Kuepfer L, Peter M, Sauer U, &, Stelling J, (2007) Ensemble modeling for analysis of cell signaling dynamics. Nat Biotechnol 25, 1001-1006. (Pubitemid 47517639)
45. Kiselyov VV, Versteyhe S, Gauguin L, &, De Meyts P, (2009) Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation. Mol Syst Biol 5, 243.
46. Ning J, &, Clemmons DR, (2010) AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation. Mol Endocrinol 24, 1218-1229.
47. Tzatsos A, &, Tsichlis PN, (2007) Energy depletion inhibits phosphatidylinositol 3-kinase/Akt signaling and induces apoptosis via AMP-activated protein kinase-dependent phosphorylation of IRS-1 at Ser-794. J Biol Chem 282, 18069-18082. (Pubitemid 47100251)
48. Jakobsen SN, Hardie DG, Morrice N, &, Tornqvist HE, (2001) 5'-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J Biol Chem 276, 46912-46916.
49. Garcia-Echeverria C, (2011) Blocking the mTOR pathway: a drug discovery perspective. Biochem Soc Trans 39, 451-455.
50. Wiznerowicz M, &, Trono D, (2003) Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 77, 8957-8961. (Pubitemid 36936105)
51. Le Novere N, Hucka M, Mi H, Moodie S, Schreiber F, Sorokin A, Demir E, Wegner K, Aladjem MI, Wimalaratne SM, et al. (2009) The Systems Biology Graphical Notation. Nat Biotechnol 27, 735-741.
52. Funahashi A, Morohashi M, Kitano H, &, Tanimura N, (2003) CellDesigner: a process diagram editor for gene-regulatory and biochemical networks. BIOSILICO 1, 159-162.
53. Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC, Kitano H, Arkin AP, Bornstein BJ, Bray D, Cornish-Bowden A, et al. (2003) The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 19, 524-531. (Pubitemid 36336519)
54. R Development Core Team (2005) A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria.